Blog

The study by staff at St George's University of London, showed that a drug called pregabalin was the most effective trial treatment. Patients took two pills daily and were treated during a three month period.

Many bones in the body, including those of the wrists and hands, are protected by cartilage. Cartilage can wear down over time. As a result, a person can experience a condition known as osteoarthritis.

A simple yet effective new treatment for rheumatoid arthritis may be in sight; researchers have now created a hydrogel that could absorb the excess joint fluid that arises with disease, as well as deliver medications to affected joints.

Hand cramping can occur for many reasons and cause significant discomfort in some people.

Hildebrand's research has shown that ketotifen, a medication used to treat asthma for over 40 years, shows promise in preventing post-traumatic contractions. Ketotifen works by inhibiting the activity of mast cells. "The prospects of using this drug to treat contractures is exciting...

Various nonoperative treatment approaches were safe and efficacious for patients with lumbar spinal stenosis, according to a presenter at the North American Spine Society.

Although sacroiliac MRI has been extensively relied on to diagnose axial spondyloarthritis, research presented at the American College of Rheumatology Annual Meeting demonstrated that similar inflammation of sacroiliac joints was observed among even healthy individuals, highlighting the need for com...

Research by a Barrow Neurological Institute neurosurgery team on novel imaging technique assessment of patients with lumbar spine degeneration was published in the Aug. 28 issue of PLOS ONE.

A new study published in the Journal of Orthopaedic Research indicates that certain genetic changes are linked with an increased risk of developing lumbar spinal stenosis, a narrowing of the open spaces in the lower spine that can lead to pain in the legs when individuals walk.

More than half of the babies with infantile-onset spinal muscular atrophy (SMA) who were treated with nusinersen (Spinraza) gained motor milestones, compared to none of the babies in the control group. Infants treated with the drug also had 63 percent lower risk of death. These final results from th...